Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.80 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.80 |
| ▸ | MAPT | P10636 | 2/20 | 0.73 |
| ▸ | FAAH | O00519 | 3/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CNR1 | P21554 | 2/20 | 0.41 |
| ▸ | CNR2 | P34972 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11327844 | 1.00 | TSHR (0.80) | TSHRSMN1; SMN2MAPTFAAHALDH1A1 | |
| SCHEMBL31362199 | 0.92 | MAPT (0.79) | TSHRSMN1; SMN2MAPTFAAHALDH1A1 | |
| SCHEMBL31362201 | 0.92 | MAPT (0.79) | TSHRSMN1; SMN2MAPTFAAHALDH1A1 | |
| SCHEMBL26092952 | 0.92 | TSHR (0.95) | TSHRSMN1; SMN2MAPTFAAHALDH1A1 | |
| SCHEMBL26094938 | 0.92 | TSHR (0.95) | TSHRSMN1; SMN2MAPTFAAHALDH1A1 | |
| SCHEMBL25702503 | 0.92 | TSHR (0.95) | TSHRSMN1; SMN2MAPTFAAHALDH1A1 | |
| SCHEMBL6687715 | 0.89 | TSHR (1.00) | TSHRSMN1; SMN2MAPTFAAHALDH1A1 | |
| SCHEMBL5364934 | 0.86 | ALDH1A1 (0.66) | TSHRSMN1; SMN2MAPTFAAHALDH1A1 | |
| SCHEMBL13346193 | 0.86 | ALDH1A1 (0.66) | TSHRSMN1; SMN2MAPTFAAHALDH1A1 | |
| SCHEMBL7202057 | 0.84 | TSHR (0.80) | TSHRSMN1; SMN2MAPTFAAHALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6756500-B1 | SUBJECTING SUBSTITUTED ALPHA, OMEGA-DIENE IN PRESENCE OF RUTHENIUM, OSMIUM OR MOLYBDENUM HOMOGENEOUS OR HETEROGENEOUS CATALYST TO METATHESIS REACTION IN PRESENCE OF IONIC LIQUID TO FORM CYCLIC COMPOUND | BAYER AKTIENGESELLSCHAFT (DE) | 2004-06-29 | — | — | US | claimed |
| EP-1035093-B1 | Metathesis in the presence of ionic liquids | BAYER AG (DE) | 2003-09-10 | — | — | EP | claimed |
| US-20170037282-A1 | ADHESIVES COMPRISING (METH)ALLYL CROSSLINKER AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-02-09 | — | — | US | disclosed |
| WO-2015157350-A1 | ADHESIVES COMPRISING (METH)ALLYL CROSSLINKER AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-10-15 | — | — | WO | disclosed |
| US-6756500-B1 | SUBJECTING SUBSTITUTED ALPHA, OMEGA-DIENE IN PRESENCE OF RUTHENIUM, OSMIUM OR MOLYBDENUM HOMOGENEOUS OR HETEROGENEOUS CATALYST TO METATHESIS REACTION IN PRESENCE OF IONIC LIQUID TO FORM CYCLIC COMPOUND | BAYER AKTIENGESELLSCHAFT (DE) | 2004-06-29 | — | — | US | disclosed |